Utrecht Holdings is the Knowledge Transfer Office (KTO) for Utrecht University and the University Medical Center Utrecht (UMC Utrecht). Their primary goal is to translate research results from these institutions into societal impact. They achieve this by providing legal, strategic, and financial support to researchers, guiding them through the process of turning inventions into real-world applications. This includes evaluating inventions for potential, securing intellectual property (often through patents), connecting researchers with industry partners and investors, and offering funding for early-stage development through their Make It Matter voucher program (up to €25,000). They support the creation of new ventures or licensing technologies to existing companies. Their operational model involves a holding structure for start-ups and strategic entities, which allows for easier transfer or sale of shares, a clear overview of participation, and harmonized operations across entities. They also focus on corporate compliance with relevant rules and regulations. Utrecht Holdings actively works within the strategic themes of their partner institutions, including Life Sciences, Digital Innovations (AI), and Sustainability. Their team possesses expertise in scientific research, business development, intellectual property, finance, investments, and legal matters, facilitating partnerships that bring new products and services to market. They embody diversity and inclusivity in their knowledge transfer approach. Utrecht Holdings focuses on facilitating knowledge transfer by assessing the impact, patentability, start-up potential, and funding needs of research results. They operate under the policies and regulations set by Utrecht University and UMC Utrecht, managed by their respective Legal Affairs units. They strive to realize societal and economic impact from research results by organizing the transfer of inventions to existing market players or establishing start-up companies. The ultimate aim is to support science-based inventions in improving patient care through novel medical devices and therapies, and contributing to a more sustainable society. They have been supporting science for 25 years.
Preferred startup development maturity for initial funding deployment.
Life Sciences, Digital Innovations (AI), Sustainability, novel medical devices, groundbreaking therapies, algorithms for healthcare, options to reduce plastics, technologies that produce less waste, alternatives to animal testing
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
